ENTITY

ResMed (RMD UN)

23
Analysis
Health Care • United States
ResMed Inc. develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.
more
bullish•HDFC Bank
•08 Feb 2026 04:17

Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (9 Feb 2026)

​Statistical methodology identifies five pair trade opportunities across three markets and three sectors, offering unique insights into relative...

Logo
325 Views
Share
bullish•ResMed Inc
•04 Feb 2026 05:47

ResMed (RMD AU)  Vs. Fisher & Paykel Healthcare (FPH AU): Aussie Statistical Arbitrage Reloaded

Repeat pair trade with a 9% target-return in this proven pair amid significant deviation of the price ratio. Opportunity for quantitative traders...

Logo
225 Views
Share
•14 Oct 2025 05:59

Long F&P Health (FPH AU) Vs. Short ResMed (RMD AU): Pair Trade with 7% Upside Potential

The price-ratio between Fisher & Paykel Health and ResMed has diverged by 2 standard deviations, offering a potential relative value opportunity...

Logo
346 Views
Share
bearish•BHP Group Ltd
•12 Oct 2025 16:16

BHP (BHP AU/US) And Woodside (WDS AU/US) Slide as U.S. Sell-Off Spills Into Australian Stocks

Friday’s U.S. market rout pushed dual-listed Australian stocks lower, with BHP and Woodside among the biggest movers. US-traded ADRs and futures...

Logo
830 Views
Share
bullish•ResMed
•23 Sep 2025 10:46

Primer: ResMed (RMD UN) - Sep 2025

Market Leader Capitalizing on Favorable Industry Dynamics: ResMed is a global leader in the sleep and respiratory care market, poised to...

Share
x